New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 5, 2012
07:27 EDTILMNCredit Suisse assesses potential M&A prices for Illumina
Credit Suisse said a potential acquisition range for Illumina is $60-$70 per share given recent public and private deals in the tools and diagnostics space. Shares are Outperform rated with a $55 price target.
News For ILMN From The Last 14 Days
Check below for free stories on ILMN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 9, 2014
08:58 EDTILMNIllumina not targeted by new Chinese regulations, says Janney Capital
Subscribe for More Information
April 7, 2014
07:30 EDTILMNIllumina weakness creates buying opportunity, says Wells Fargo
Wells Fargo believes that the recent decline in Illumina's stock is mostly related to its correlation with biotech indices, and the firm sees this correlation as "a technical rather than a fundamental phenomenon." The firm believes that demand for the company's HiSeq, MiSeq, and HiSeq X instruments are strong, and it now identifies the stock as its top pick in the tools space. It increased its price target on the shares to $170-175 from $155-$160.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use